EBM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Evidence-Based Medicine 2006;11:18; doi:10.1136/ebm.11.1.18
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindbaek, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindbaek, M.
Topic Collections
Right arrowRelevant Article

Therapeutics

Topical chloramphenicol was not effective in children with acute infective conjunctivitis

Rose PW, Harnden A, Brueggemann AB, et al. Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial. Lancet 2005;366:37–43.[CrossRef][Medline]

Q In children with acute infective conjunctivitis, is topical chloramphenicol effective for inducing clinical cure?

Clinical impact ratings GP/FP/Primary care ******{star} Infectious disease ******{star} Paediatrics ******{star}

Key Words: chloramphenical • conjunctivitis (bacterial) • conjunctivitis (viral)

The first 150 words of the full text of this article appear below.

METHODS
Formula Design: randomised controlled trial.

Formula Allocation: concealed.*

Formula Blinding: blinded (patients, healthcare providers, data collectors, outcome assessors, and data analysts).*

Formula Follow up period: 7 days for the primary outcome plus an extra 5 weeks to assess relapse.

Formula Setting: 12 primary care practices in Oxfordshire, UK.

Formula Patients: 326 children 6 months to 12 years of age who had acute infective conjunctivitis. Exclusion criteria included an allergy to chloramphenicol, use of an antibiotic (current or within the previous 48 h), evidence of severe infection, and children who were immunocompromised.

Formula Intervention: 0.5% chloramphenicol (preservative free eye drops BP) (n = 163) or placebo (distilled water with the excipients boric acid, 1.5%, and borax, 0.3%) (n = 163). Parents were instructed to put 1 drop in each of their child’s affected eye every 2 hours for the first 24 hours when their child was awake and then 4 times daily until 48 hours after the infection . . . [Full text of this article]

Morten Lindbaek, MD

University of Oslo
Oslo, Norway


Relevant Article

Glossary
Evid. Based Med. 2006 11: 31. (in Glossary) [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Evid. Based Med.Home page
K. M Qureshi, S. Robbie, S. Kashani, and P. Rose
Viral infections need to be excluded from the cohort for the results to be truly meaningful * Author's reply
Evid. Based Med., June 1, 2007; 12(3): 93 - 93.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.